Your browser doesn't support javascript.
Management of Lung Cancer During the COVID-19 Pandemic.
Singh, Aditi P; Berman, Abigail T; Marmarelis, Melina E; Haas, Andrew R; Feigenberg, Steven J; Braun, Jennifer; Ciunci, Christine A; Bauml, Joshua M; Cohen, Roger B; Kucharczuk, John C; Shulman, Lawrence N; Langer, Corey J; Aggarwal, Charu.
  • Singh AP; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Berman AT; Abramson Cancer Center, Philadelphia, PA.
  • Marmarelis ME; Abramson Cancer Center, Philadelphia, PA.
  • Haas AR; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
  • Feigenberg SJ; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Braun J; Abramson Cancer Center, Philadelphia, PA.
  • Ciunci CA; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Bauml JM; Abramson Cancer Center, Philadelphia, PA.
  • Cohen RB; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
  • Kucharczuk JC; Abramson Cancer Center, Philadelphia, PA.
  • Shulman LN; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Langer CJ; Abramson Cancer Center, Philadelphia, PA.
  • Aggarwal C; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
JCO Oncol Pract ; 16(9): 579-586, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-378256
ABSTRACT
Coronavirus disease 2019 (COVID-19) has had a devastating impact around the world. With high rates of transmission and no curative therapies or vaccine yet available, the current cornerstone of management focuses on prevention by social distancing. This includes decreased health care contact for patients. Patients with lung cancer are a particularly vulnerable population, where the risk of mortality from cancer must now be balanced by the potential risk of a life-threatening infection. In these unprecedented times, a collaborative and multidisciplinary approach is required to streamline but not compromise care. We have developed guidelines at our academic cancer center to standardize management of patients with lung cancer across our health care system and provide guidance to the larger oncology community. We recommend that general principles of lung cancer treatment continue to be followed in most cases where delays could result in rapid cancer progression. We recognize that our recommendations may change over time based on clinical resources and the evolving nature of the COVID-19 pandemic. In principle, however, treatment paradigms must continue to be individualized, with careful consideration of risks and benefits of continuing or altering lung cancer-directed therapy.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Lung Neoplasms Type of study: Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: JCO Oncol Pract Year: 2020 Document Type: Article Affiliation country: OP.20.00286

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Lung Neoplasms Type of study: Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: JCO Oncol Pract Year: 2020 Document Type: Article Affiliation country: OP.20.00286